572 related articles for article (PubMed ID: 32829388)
21. Efficiency and efficacy of vitrification in 35 654 sibling oocytes from donation cycles.
Cornet-Bartolomé D; Rodriguez A; García D; Barragán M; Vassena R
Hum Reprod; 2020 Oct; 35(10):2262-2271. PubMed ID: 32856058
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles.
Fadini R; Mignini Renzini M; Guarnieri T; Dal Canto M; De Ponti E; Sutcliffe A; Shevlin M; Comi R; Coticchio G
Hum Reprod; 2012 Dec; 27(12):3601-8. PubMed ID: 23042796
[TBL] [Abstract][Full Text] [Related]
23. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
[TBL] [Abstract][Full Text] [Related]
24. Season at the time of oocyte collection and frozen embryo transfer outcomes.
Leathersich SJ; Roche CS; Walls M; Nathan E; Hart RJ
Hum Reprod; 2023 Sep; 38(9):1714-1722. PubMed ID: 37407029
[TBL] [Abstract][Full Text] [Related]
25. How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes.
Solé M; Santaló J; Boada M; Clua E; Rodríguez I; Martínez F; Coroleu B; Barri PN; Veiga A
Hum Reprod; 2013 Aug; 28(8):2087-92. PubMed ID: 23744895
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two different oocyte vitrification methods: a prospective, paired study on the same genetic background and stimulation protocol.
Pujol A; Zamora MJ; Obradors A; Garcia D; Rodriguez A; Vassena R
Hum Reprod; 2019 Jun; 34(6):989-997. PubMed ID: 31116386
[TBL] [Abstract][Full Text] [Related]
27. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF/ICSI.
Mostinckx L; Goyens E; Mackens S; Roelens C; Boudry L; Uvin V; Segers I; Schoemans C; Drakopoulos P; Blockeel C; De Vos M
Hum Reprod; 2024 Mar; 39(3):586-594. PubMed ID: 38177084
[TBL] [Abstract][Full Text] [Related]
29. Human-induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation.
Piechota S; Marchante M; Giovannini A; Paulsen B; Potts KS; Rockwell G; Aschenberger C; Noblett AD; Figueroa AB; Sanchez M; Barrachina F; Wiemer K; Guzman L; Belchin P; Pierson Smela M; Fortuna PRJ; Chatterjee P; Tran ND; Kelk DA; Forti M; Marcinyshyn S; Smith T; McCulloh DH; Fernandez-Gonzalez MJ; Abittan B; Ortiz S; Klein JU; Klatsky P; Ordonez-Perez D; Kramme CC
Hum Reprod; 2023 Dec; 38(12):2456-2469. PubMed ID: 37815487
[TBL] [Abstract][Full Text] [Related]
30. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
[TBL] [Abstract][Full Text] [Related]
31. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
[TBL] [Abstract][Full Text] [Related]
32. How to identify patients who would benefit from delayed-matured oocytes insemination: a sibling oocyte and ploidy outcome study.
Elkhatib I; Nogueira D; Bayram A; Abdala A; Del Gallego R; Melado L; De Munck N; Lawrenz B; Fatemi H
Hum Reprod; 2023 Aug; 38(8):1473-1483. PubMed ID: 37344149
[TBL] [Abstract][Full Text] [Related]
33. Is in vitro maturation of oocytes retrieved ex vivo from ovarian tissue an effective fertility preservation technique in the presence of organic ovarian cysts?
Bourg M; Moreau J; Carles M; Cadoret F; Lesourd F; Tournier A; Léandri RD; Gatimel N
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():87-91. PubMed ID: 36586210
[TBL] [Abstract][Full Text] [Related]
34. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
35. A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies.
Kato K; Ochi M; Nakamura Y; Kamiya H; Utsunomiya T; Yano K; Michikura Y; Hara T; Kyono K; Takeuchi K; Nakayama T; Iwamasa J; Mio Y; Kuramoto T; Nagata Y; Jo T; Asada Y; Ohishi H; Osada H; Yoshida H
Hum Reprod Open; 2021; 2021(1):hoaa064. PubMed ID: 33501384
[TBL] [Abstract][Full Text] [Related]
36. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
[TBL] [Abstract][Full Text] [Related]
37. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN
Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
[TBL] [Abstract][Full Text] [Related]
38. Effective protection: the embryonic development and clinical outcomes of emergency vitrification of 1246 oocytes and Day 0-Day 5 embryos in a natural disaster.
Song W; Zhang F; Wang Y; Shi H; Sun N; Jin H; Wang X; Guo Y; Hu L; Zhai J; Dai S; Zhang Y; Su Y; Yao G; Shi S; Wen S; Song N; Wu Z; Chen L; Cheng T; Kang B; Sun J; Huang X; Sun Z; Cheng L; Liang Y; Sun Y
Hum Reprod; 2023 Dec; 38(12):2412-2421. PubMed ID: 37846525
[TBL] [Abstract][Full Text] [Related]
39. Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?
Mackens S; Pareyn S; Drakopoulos P; Deckers T; Mostinckx L; Blockeel C; Segers I; Verheyen G; Santos-Ribeiro S; Tournaye H; De Vos M
Hum Reprod; 2020 Oct; 35(10):2272-2279. PubMed ID: 32951028
[TBL] [Abstract][Full Text] [Related]
40. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence.
Santiquet NW; Greene AF; Becker J; Barfield JP; Schoolcraft WB; Krisher RL
Mol Hum Reprod; 2017 Sep; 23(9):594-606. PubMed ID: 28586460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
